regulatory
confidence high
sentiment positive
materiality 0.65
GeoVax Labs regains Nasdaq compliance with $8.5M stockholders' equity
GeoVax Labs, Inc.
- Received Nasdaq notice on Nov 18, 2024 confirming compliance with Listing Rule 5550(b)(1) based on $8,503,876 stockholders' equity as of Sep 30, 2024.
- Previously received extension until Nov 19, 2024 to cure deficiency; matter now closed.
- Company had been notified of non-compliance on May 23, 2024 due to insufficient stockholders' equity.
- Maintains listing on Nasdaq Capital Market; common stock trades under GOVX and warrants under GOVXW.